
(ééèæ³äººã®)éå°åµååé¡ãžã®æ¥è¿æ¹æ³ãFSB DP 22 Feb. 2022
Approaches to Debt Overhang Issues of Non-financial Corporates, FSB Discussion Paper Feb.22, 2022Â
ããŸã2007-2008幎ã®éèææ ã«ãã£ãŠæ·±å»åããéå°åµååé¡ãããŸã ååçããªãéã«ãCOVID-19 äžççãªãã³ãããã¯(ææçã®äžçç倧æµè¡)ã«ããïŒ2020幎2æ2æ¥ããã€ã€ã¢ã³ãããªã³ã»ã¹å·ã®æšªæµç岞ïŒãäžçååœã§åµååé¡ãäžæ®µãšæ·±å»ã«ãªã£ããšããèªèããã®èªèããŸãã¯ãã®ã¬ããŒãã§ç¢ºèªããããã€ãŸãéå°åµååé¡ãäŸç¶ç¶ç¶ããŠããããããŠ2022幎ã«å ¥ã£ãŠä»¥éã¯ããã·ã¢ã«ãããŠã¯ã©ã€ã䟵æ»(2022幎2æ24æ¥éæŠ)ã«ããäžççµæžã®æ··ä¹±ãåºãã£ãŠããããã®ãããªäžçæ å¢ã®ããšã§ãèœã¡çããŠè°è«ãé²ããããšã¯ãªããªããã€ããããäžé·æçã«ç¢ºãã ãšæãããããšãåºæºã«è°è«ãé²ãããããªããïŒçŠå ïŒ
èæ¯ãå
Œ
±åœå±ã«ããéåžžãšã¯ç°ãªãæ¿ç察å¿ã¯ãCOVID-19 pandemicã®çµæžçæŸå°èœæ±æãå¶éããéµã ã£ããè¿
éã§ãšãŠãå€§èŠæš¡ãªæ¿ç察å¿ã¯ãçŸå®ã®çµæžãšéèã·ã¹ãã ãžã®ã·ã§ãã¯ã®ãã€ãã¹ã®å¹æãåãããã®ã«åœ¹ç«ã£ããäžççãªéèææ
以æ¥å¢å ãã察å¿èœåãšãšãã«ããããã®ææ®µã¯ããšãŠãé·ãæ¯æ°åŸéãšãã·ã¹ãã ããã¯ãªéèææ
ãšã鲿¢ããããã§ãéèŠã ã£ãããããã®ææ®µã¯ããšãŠãé·ãæ¯æ°åŸéãšã·ã¹ãããã¯ãªéèææ
ãšã鲿¢ããããã§éèŠãªåœ¹å²ãæŒããéèæ©é¢ã«ã¯ãããå€ãã®æ
å ±ãå©çšå¯èœãšãªãããã«ãæ³äººãšäºæ
ã®çåå¯èœæ§ãå€å®ããæéãæäŸãããçµæžãšäŒç€Ÿãšãå埩ãå§ãããšå
Œ
±åœå±ã¯ãæœåšçã«éå°ãªäŒæ¥ã®åµåãåå ãšãªã£ãŠåŒãèµ·ããåé¡ã«åãçµãããšãæåŸ
ãããã2021幎1æã«å°å·ããããéèå®å®å§å¡äŒïŒFSBïŒã®ã¬ããŒããéèå®å®ã®èŠè§ãããCOVID-19 PandemicããåŠãã æèšã«ã€ããŠã®å ±åãã¯ãåµåéå°åé¡ãFSBã®æ³šæãä¿èšŒããã倧ããªæ¿çåé¡ã®äžã€ãšããŠæèµ·ãããã€ãFSBãåµåéå°åé¡ãæ±ãå¯èœãªæ¥è¿æ³ïŒæ¹çïŒãç ç©¶äžã§ããããšã瀺åããããã®è«æã®ç®çã¯ãCOVIDåŸã®ç°å¢ã®äžã§éå°åµååé¡ã®çŸå®çç¯å²ã«ã€ããŠå
¬è¡ã®èŠè§£ãéããããšããããŠéèåœå±ãšãéèæ©é¢ããªã¹ãã©ã®å°éå®¶ãåãæãå«ãå€éšã®å©å®³é¢ä¿è
ãšéã§ãéå°åµååé¡ããã®åæ»ãªè»¢æãæ¯æããã®ã«å¹æçãªãæ¿ççã¢ãããŒããšåžå Žã®æ
£è¡ãšã«ã€ããŠã®å¯Ÿè©±ã容æã«ããããšã§ããããã®è«æã¯ãæ¹çã®ç¹å®ã®çµã¿åãããæšå¥šããããšãç®çãšããŠããªããïŒäžç¥ïŒ
èŠçŽãå
Œ
±åœå±ã®éåžžãšã¯ç°ãªãæ¿ç察å¿ã¯ãCOVID-19ãã³ãããã¯ã®çµæžçæŸå°èœæ±æãéå®ããéµã ã£ããåæã«ïŒçŽæ¥ãããŠè²žä»ä¿èšŒãšããïŒå€§éã®å
Œ
±ä¿¡çšäŸäžã¯ãééèäŒç€Ÿã«åäŸã®ãªãåµåæ°Žæºãããããããããã€ãã®æ³æ²»åã«ãããŠã¯åµåæ°Žæºãšãšãã«çŸéä¿æãå¢å ãããããã³ãããã¯ã®éãGDPã®ããžã·ã§ã³ã«å¯Ÿãã諞åœã®éèšãããçŽåµåã¯äžè¬çã«å¢å ããããã®èæ¯ã®ããšã§FSBã¯ã2021幎4æã®COVID-19æ¯æŽææ®µã«ã€ããŠã®å ±åã§ãéå°åµåãé·åŒãæ¿çæ¯æŽããçãåŸãéèŠãªãªã¹ã¯ãšèªèããã
ãæ³äººãšå人起æ¥å®¶ã®éå°åµåã¯ãâ éå°åµåäžã§çåå¯èœãªæ³äººã«ããéå°æè³ãâ¡çåã§ããªãæ³äººã«è³éäŸçµŠããããšã§ã®è³æºã®èª€ã£ãé
åãâ¢èµ·æ¥èœåã®åªå€±ã«ããäœçç£æ§ããéããŠãæ³æ²»åã®çµæžå埩ã«é害ãçã¿åºãããããéèã®å®å®æ§ã«ãªã¹ã¯ã課ããããåºæ±ãªåµåäžå±¥è¡ãšãåµåæ¯æãèœåãæ¬ åŠãããªã¹ã¯ããããå ããŠã貞ãæã®å¥å
šæ§ãšäž»æš©è
ãšã®éã«ã¯åé¢ããããå
çé¢ä¿ãããã
  å¥å
šãªéèå¶åºŠã¯ãéå°åµååé¡ã«æ³šç®ããå ŽåãéèŠã§ãããéããŸãçã§ãããéèã®æäŸè
ãšããŠéèæ©é¢ã¯ãåµåã®ãªã¹ãã©åé¡ã§ãã·ã¹ãã å
šäœã§éå°åµååé¡ã解決ããããã§ãåãæã«ã€ããŠã®ãã®è±å¯ãªæ
å ±çšããããšã§éèŠãªåœ¹å²ãæŒããŠãããåãé貚ã®è£åŽã§ã¯ãéè仲仿©é¢ã¯ãéå°åµåã®è² ã®çµæžå¹æã«ãããé¡§å®¢ã®ææãä¿¡çšããŒããã©ãªãªãéããŠåœ±é¿ãåããŠãããããããéèåœå±ã«ã¯ãéå°åµååé¡ããéèå®å®ãªã¹ã¯ãçŸå®åããããšã鲿¢ããããã§ãéè仲仿©é¢ããã®åé¡ã®è§£æ±ºã®äžéšã§ããããã«åæ©ä»ãã圹å²ãããã
  ãã®è«æã¯éå°åµååé¡ã3ã€ã®è§åºŠããèŠãŠãããâ COVID-19ã®ç°å¢ã«ãããæ³äººã®çåå¯èœæ§ãããã«è©äŸ¡ããããâ¡çåã§ããäŒç€Ÿã®åµåã®é©åãªæç¹ã§ã®ãªã¹ãã©ãšè³éå調éãããã«å®¹æã«ãåæ©ä»ããããçåã§ããªãäŒç€Ÿã®éåºãããã«å®¹æã«ããããâ¢å°äžèŠæš¡ã®äŒæ¥ã埮å°äŒç€Ÿã«ãšãã«æ³šæãã€ã€ãåµåãªã¹ãã©ã®äºãŒãºãæã€å€ãã®äŒç€Ÿãããã«åãæ±ãããïŒäžç¥ïŒ
æ¬æã2ïŒéèã®å®å®æ§ã«ãšã£ãŠã®å«æ
ãæ³äººãããŠå人起æ¥å®¶ã®éå°åµåã¯,3ã€ã®é·æåé¡ãåŒãèµ·ãããããâ çåå¯èœãªæ³äººã®éå°åµåãåŒãèµ·ããéå°æè³ãâ¡çåäžå¯èœãªæ³äººã«å¯Ÿãã誀ã£ãè³æºåé
ããããŠâ¢èµ·æ¥èœååªå€±ã«ããçç£æ§ã®åªå€±ã§ãããçµæžåŠè
ãã¡ã¯ããããã®åé¡ãç¹ã«æåã®äºã€ã®ãäŒç€Ÿãšããåºãçµæžã®æé·ãšåŒ·åãªå埩ã«ãšã£ãŠã®æå®³ãªåœ±é¿ã«ã€ããŠãé·ãéãè°è«ããŠããã
ãéå°åµåãåŒãèµ·ããéå°æè³ãéå°åµåãšããçšèªã®æšæºçå®çŸ©ã¯ãééèæ³äººã«çããéå°åµåã®éè·ã«èšåããŠãããéå°åµåã¯ãæ³äººã«ãšã£ãŠãã©ã¹ã®çŸåšäŸ¡å€ããã€æè³ã®ãã貚幣ãå調éããèªå ãæžå°ãããããšããã®ã¯ããããã®æè³ããã®åå
¥ã®ã»ãšãã©ã¯ãçŸåšã®æ ªäž»ãæ°ããªæè³å®¶ã«å¯ŸããŠæ¯æãããã®ã§ã¯ãªããæ¢åã®åµæš©è
ãä¿æããåµåã®æ¯æãã«ã€ããããã§ãããããã§ãããããã§éå°åµåã¯éå°æè³ãå°ãããããŠçµæžã®ç£åºãšçç£æ§ã®èœã¡ãã¿ãããããã®ã§ããã
ãçåäžå¯èœãªæ³äººã«å¯Ÿããè³æºã®èª€ã£ãåé
ããã®è³ç£ã®æž
ç®äŸ¡å€ãç¶ç¶äœãšããŠã®ãã®äŸ¡å€ããé«ããšããäŒç€Ÿã¯çåäžå¯èœãšã¿ãªããããæž
ç®ãããŠããªãçåäžå¯èœãªäŒç€Ÿã¯ãä»ã®äŒç€Ÿãäºæ¥æ©äŒãã€ããããšã劚ããŠãããæ°ããªäŒç€Ÿã®åå
¥ã«æµæããŠããã人ããã®ä»ã®è³ç£ãæããŠãããïŒãã®ãã¹ãŠãïŒããäœãç·æè³ãããã¯çµæžæé·ã«ã€ãªãã£ãŠãããç¶æ³ã®ç·æ¥æ§ãæ¥æ¿ãªæ¯æŽãå¿
èŠãšããã®ã§ãããã倧éã®æ¿çããã±ãŒãžãçåäžå¯èœãªæ³äººã®ç¶æã«ã€ãªãã£ããã¯æžå¿µãšãªãã ããã倧ããªä¿¡çšä¿èšŒã®åœã
ã§ã¯ãä¿¡çšã®åé
åã¯å°ãªãã£ããCOVID-19åŸã®ææã«ãããŠãçåäžå¯èœãªæ³äººãžã®æœåšçè³æºã®èª€ã£ãåé
ã®åé¡ã¯ããéèŠãªèª²é¡ã«ãªãããªããªãå°çèŠæš¡ã®æ§é å€åã¯ãããæ©ãæå³ã®ããè³æºã®ååé
ãæ±ããããã§ãããïŒäžç¥ïŒ
ïŒïŒåµåãªã¹ãã©ãšçåå¯èœãªäŒç€Ÿãžã®æ°ããªè²šå¹£ã®äŸçµŠ
4.1  æŠèг
ãäŸç¶ãšããŠçµæžçã«çåå¯èœãªããžãã¹ã¢ãã«ãæã€å°çª®äŒç€Ÿã¯ãé©åãªãã©ã³ã¹ã·ãŒãã®ãªã¹ãã©ãåããã¹ãã§ããããã®ããšã¯ããåºãçµæžã«ãã©ã¹ã®åœ±é¿ããããã嵿š©è
åŽã®é·æçãªå©å®³ã§ãããã¹ãã ããããæ£ããæ¹æ³ãšæ
£è¡ãæ¬ ããŠã¯ããã®ããšïŒãªã¹ãã©ïŒã¯èµ·ããããéè¡ã®äœãåçæ§ãäœãæè³ãšçç£æ§ããããŠéèå®å®ãªã¹ã¯ã«ã€ãªããã ãã§ãããïŒäžç¥ïŒ
Box.4Â éžæãããåµåãšåæ ªåŒïŒhybridïŒã®éå
·
äºé転æåµdoble convertible debt Â
ãæè³å®¶ã«å¯ŸããŠè»¢æåµã¯ãä¿æåµåããããããå®ããããæ ªæ°ã«äº€æããååŒæãžã®ãªãã·ã§ã³ãäžããŠãããææè
ã¯çºè¡äŒç€Ÿã®æ ªäŸ¡ãäžæãããšå©çãã§ãã転æåµã¯ãã®äŒç€Ÿã®æ ªåŒäŸ¡æ Œäžæã«åå ããæ©äŒãæäŸããã®ã§ãéåžžã®åµåžããäœãã¯ãŒãã³ã¬ãŒãŒãã§çºè¡ããããã
ãäºé転æåµã¯ããã®ææè
ã«åµåžãåºå®ããã䟡å€ã§åµåžãæ ªåŒè»¢æããããšãèš±ãäºçªç®ã®ãªãã·ã§ã³ãå«ãã§ãããæ ªäŸ¡ãäžèœãããšè»¢æåµä¿æè
ã¯ããå€ãã®æ ªåŒã«è»¢æããæš©å©ããã€ãæçµçã«ååäœãäŸ¡æ Œã§ã¯ãä¿æè
ã¯ããã®äŒæ¥ãæ¯é
ããå°ã«ååãªæ ªæ°ãäžããããã
ç¶æ³äŸååµstate contingent debtÂ
ãç¶æ³äŸååµåïŒè²žä»ïŒæ¡é
ã«ãããå
éãšå©åã®è¿æžããçµæžã®ç¶æ³ãšçµã³ä»ããããŠãããç£æ¥ãããã¯äºæ¥èªèº«ãäžå©ãªç¶æ³ãããã°ãæ¯æãã¯èªåçã«åæ¢ããããããã¯ããªãåæžããããïŒäžç¥ïŒã
åªå
æ ªpreferred equity
  åªå
æ ªã¯ãã€ã«ãŒã·ã§ã³ïŒæ ªåŒã®æš©å©ã®åžèåã®ããšïŒã䌎ããªããé«äŸ¡ã§ãããããããã³ãªã³ãŒã¹ã®è³éèª¿éæ¹æ³ãæäŸããŠãããåªå
æ ªã®ææè
ã¯é
åœã®åãåããšæž
ç®æã«ãããŠãæ®éæ ªã®ææè
ã«æ¯ã¹ãŠãã£ãšãŸãã£ãäœçœ®ãå ããŠãããïŒäžç¥ïŒ
Box 6ãåµåååã®æ³äººçšãžã®çç®ãæ³äººæ ªåŒãžã®å²ãåœãŠã
ãæ³äººæåŸçšå¶ã¯äžè¬çã«äŒç€Ÿåµåãžã®å©åã®æ§é€ãèš±ããŠããããæ ªåŒãžã®å ±é
¬ã¯çšæ§é€ã§ããè²»çšã§ã¯ãªããè³éæºæ³ã®éã®çšå¶ã®æ±ãã®é察称æ§ã¯ãæ ªåŒãè³éæºãšããå Žåã®è³éã³ã¹ããå¢ãããåµåååããçã¿åºãããããªããã°éžæãããæ°Žæºãè¶
ããŠåµåã®äœ¿çšãå±ãŸããŠããããã®åµåååã¯ãããé«ãåµåäžå±¥è¡ãªã¹ã¯ãåµåæ¯æãèœåã®æ¬ åŠããããŠæ¯æ°åŸªç°ã§ã®å€åå¶ãé«ããŠãããå®èšŒçæç®ã¯ãééèäŒæ¥ãšåµåååãšã®é¢ä¿ã確èªããŠããã
ãåµåååã«åãçµãããã®äžã€ã®å¯èœãªæ¹æ³ã¯ãæ³äººæ ªåŒãžã®å²åœäœå¶ACEã§ããããã®ACEäœå¶ã®äžã§ã¯ãåµåã®ã³ã¹ãã®æ§é€ãšäžŠè¡ããŠãäŒç€Ÿã¯æ ªåŒã«å¯Ÿããåž°å±å ±é
¬ãæ³äººæåŸçšããŒã¹ããæ§é€ã§ãããæ ªåŒãžã®åž°å±å ±é
¬ã¯ãæ³äººã®é·æåµåã®ãžã®å¹³åå©åãšçãããªãã ãããååã«ãããŠãã®çšå¶ã¯ãéèéžæãæªããªãããæè³ã®æé©æ°Žæºã«ã圱é¿ããªããïŒä»¥äžç¥ïŒïŒè𳿳šããã®è°è«ã¯åµåãšæ ªåŒãšã®çè«çå·®ç°ãç¡èŠããŠããã®ã§éåæããããæ ªåŒã«åºè³ãããšããããšã¯èªå·±è³æ¬ã«åºè³ãããã€ãŸãçµå¶ãªã¹ã¯ãè² æ
ãããšããããšã§ãããå©åãšåãã«ãªããšããã®ã¯ãããããïŒ(以äžç¥)